Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NINJA: 3D Regimen for HCV Genotype 2K/1B
NCT03050905Phase 4Completed
- Sponsor
- Emek Medical Center
- Start
- Jun 2017
- Primary completion
- Nov 2017
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of paritaprevir, dasabuvir in hepatitis C (HCV), sponsored by Emek Medical Center. Started Jun 2017; status: completed.
02
Drugs
paritaprevirdasabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03050905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050905.